{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:33:09Z","timestamp":1778049189358,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":7068,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1023\/a:1008333229936","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"1115-1120","source":"Crossref","is-referenced-by-count":50,"title":["Identification of prognostic subgroups among patients with metastatic \u2018IGCCCG poor-prognosis\u2019 germ-cell cancer: An explorative analysis using cart modeling"],"prefix":"10.1016","volume":"11","author":[{"given":"C.","family":"Kollmannsberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Meisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008333229936_bb0005","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199707243370406","article-title":"Medical progress: Testicular germ-cell cancer","volume":"337","author":"Bosl","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008333229936_bb0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/bjc.1983.99","article-title":"The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)","volume":"47","author":"Peckham","year":"1983","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008333229936_bb0015","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM198706043162302","article-title":"Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide","volume":"316","author":"Williams","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008333229936_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-199958020-00004","article-title":"Diagnosis and treatment of patients with testicular germ-cell cancer","volume":"58","author":"Hartmann","year":"1999","journal-title":"Drugs"},{"key":"10.1023\/A:1008333229936_bb0025","first-page":"3403","article-title":"Multivariate analysis of prognostic variables in patients with metastatic testicular cancer","volume":"43","author":"Bosl","year":"1983","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008333229936_bb0030","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/JCO.1986.4.3.400","article-title":"Prognostic factors for favorable outcome in disseminated germ-cell tumors","volume":"4","author":"Birch","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0035","first-page":"8","article-title":"Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: Results of a multicenter study","volume":"1","year":"1985","journal-title":"Lancet"},{"key":"10.1023\/A:1008333229936_bb0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ-Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ-cell cancers","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0045","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1200\/JCO.1998.16.4.1287","article-title":"Randomized comparison of cisplatin and etoposide and either bleomycin or lfosfamide in treatment of advanced disseminated germ-cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study","volume":"16","author":"Nichols","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0050","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1991.9.7.1163","article-title":"Randomized study of cisplatin dose intensity in poor-risk germ-cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol","volume":"9","author":"Nichols","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000011854","article-title":"Current trends in chemotherapy for metastatic nonseminomatous testicular germ-cell tumors","volume":"55","author":"Bokemeyer","year":"1998","journal-title":"Oncology"},{"key":"10.1023\/A:1008333229936_bb0060","series-title":"Computational Statistics","article-title":"Classification and regression trees (CART) used for the exploration of prognostic factors measured on different scales","author":"Lausen","year":"1994"},{"key":"10.1023\/A:1008333229936_bb0065","series-title":"Classification and Regression Trees","author":"Breiman","year":"1984"},{"key":"10.1023\/A:1008333229936_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"Am J Stat Assoc"},{"key":"10.1023\/A:1008333229936_bb0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000474591","article-title":"Prognostic factors for metastatic testicular germ-cell tumours: The Memorial Sloan-Kettering cancer model","volume":"23","author":"Bosl","year":"1993","journal-title":"Eur Urol"},{"key":"10.1023\/A:1008333229936_bb0080","first-page":"202","article-title":"Prognostic factors in metastatic non-seminomatous germ-cell tumours","volume":"23","author":"Stoter","year":"1993","journal-title":"An interim analysis of the EORTC GU-Group experience. Eur Urol"},{"key":"10.1023\/A:1008333229936_bb0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000474593","article-title":"Prognostic factors in metastatic non-seminomatous germ-cell tumours: The Medical Research Council studies","volume":"23","author":"Mead","year":"1993","journal-title":"Eur Urol"},{"key":"10.1023\/A:1008333229936_bb0090","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1991.9.5.818","article-title":"Prognostic factors in unselected patients with nonseminomatous metastatic cancer: A multicenter experience","volume":"9","author":"Aass","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0095","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1200\/JCO.1998.16.2.702","article-title":"Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indiana University experience","volume":"16","author":"Saxman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0100","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.1997.15.7.2546","article-title":"High-dose carbo-platin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ-cell tumors","volume":"15","author":"Motzer","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0105","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1200\/JCO.1999.17.11.3450","article-title":"First-line high-dose chemotherapy compared to standard-dose PEB\u2013VIP chemotherapy in patients with advanced germ-cell tumors: A multivariate and matched pair analysis","volume":"17","author":"Bokemeyer","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0110","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1200\/JCO.1994.12.11.2277","article-title":"Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ-cell tumors","volume":"12","author":"Motzer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1999.17.2.509","article-title":"Phase II trial of gem-citabine in refractory germ-cell tumors","volume":"17","author":"Einhorn","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0120","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1200\/JCO.1999.17.2.512","article-title":"Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer","volume":"17","author":"Bokemeyer","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008333229936_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1008369614634","article-title":"Treatment for poor-prognosis metastatic germ-cell tumours: Much heat but, yet, little light","volume":"10","author":"Anthoney","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008333229936_bb0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF01221188","article-title":"Treatment of stage I testicular cancer and the possible role for new biological prognostic markers","volume":"122","author":"Bokemeyer","year":"1996","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420311947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420311947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/9\/1115\/19478398\/11-9-1115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:37:00Z","timestamp":1582166220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420311947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0923753420311947"],"URL":"https:\/\/doi.org\/10.1023\/a:1008333229936","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}